Ms Anam Bilgrami

Ms Anam Bilgrami

PHD Student

 Ms Anam Bilgrami                                                                
PHD Student

Phone: (02) 9850 2999
Address: Suite 3-4, Level 1, EMCBuilding
3 Innovation Road, Macquarie Park, 2109

Research interests
Health economic modelling and forecasting
Decision analysis in health (cost-effectiveness, cost-utility, cost-benefit)
Cost of illness and burden of disease studies
Valuation studies


Anam Bilgrami is a scholarship-holder and PhD candidate at MUCHE. She received a grade of 91% for her Master of Research thesis on private health insurance reforms in Australia, which was the highest mark in the Faculty of Business and Economics in 2016. She presented her research findings at the Australian Annual Health Economics Society Conference 2016

Prior to going on Parental Leave in 2014, Anam worked for six years in the Health Economics team at Deloitte/Access Economics, most recently as a Manager. During this time, she gained significant experience in policy analyses, decision analysis in health and disease-cost burden analyses. Anam was involved in a number of high profile research projects during her time as a health economist, the most recent being a detailed multi-country study on the burden of eye diseases (Australia, UK, Germany, France, Italy, Spain, Slovakia). She also undertook an economic analysis of hospital in the home care in Australia, and presented her findings at the Hospital in the Home Society of Australasia's Annual Conference 2011.

Anam has great passion for and commitment towards producing high quality health economics research.  Her academic awards include:

  • Grade of 91% on MRes thesis
  • Vice Chancellor’s Commendation for Academic Excellence - undergraduate (GPA 4.0/4.0)
  • MQ Merit Certificates for Outstanding Academic Performance in the Years 2005-2008
  • First Place with a Grade of 100% Environmental Economics Unit at Macquarie
  • MQ 2007 Victor Argy Prize for Proficiency in Macroeconomic Policy (shared First Place)
  • MQ 2006 Finance Prize for Proficiency in Financial Management (First Place).

Publications and reports

  • Report for Novartis - The economic cost and burden of eye diseases and preventable blindness (2013)
  • Report for AstraZeneca Australia, ACS in Perspective: The importance of secondary prevention (2011)
  • Report for Imaging Partners Online, Demand and supply of Magnetic Resonance Imaging In the Hunter Region (2011)
  • Report for Boehringer Ingelheim, Off beat: Atrial fibrillation and the cost of preventable strokes (2011)
  • Report for Hospital in the Home Society of Australasia, Economic analysis of Hospital in the Home (2011)
  • Report for Kidney Health Australia, Two of a KinD: The burden of diabetic kidney disease and the cost effectiveness of screening people with type 2 diabetes for chronic kidney disease (2011)
  • Report for The Gut Foundation, Cost effectiveness of screening for bowel cancer (2011)
  • Report for the National Council for the Blind of Ireland, The economic impact of vision impairment and blindness in the Republic of Ireland (2011)
  • Report for Department of Immigration & Citizenship, Economic analysis of the significant cost threshold (2010)
  • Report for Medibank Private, Tools for independent healthy ageing: Analysis of strategies for healthy ageing (2010)
  • Report for Department of Families, Housing, Community Services and Indigenous Affairs, Positive Family Functioning (2010)
  • Report for Vision 2020 Australia, Clear Focus - The economic impact of vision loss in Australia in 2009 (2010)
  • Report for Australian Nursing Federation, Nurses in residential care (2009)
  • Report for Orygen Youth Health Research Centre, The economic impact of youth mental illness and the cost effectiveness of intervention (2009)
  • Report for Alzheimer's Australia, Keeping Dementia Front of Mind (2009)
  • Report for Department of Families Housing, Community Services and Indigenous Affairs, Scoping Study for the goods and services produced from positive family functioning (2009)
Back to the top of this page